Time to Celebrate

Building upon a legacy of innovation: celebrating 10 years of the Fogarty Institute for Innovation.

  • Days
  • Hours
  • Minutes
  • Seconds
BUY TICKET DONATE
Logo

ABOUT THE EVENT

Wine with Heart combines the finer things in life: delectable food, the best local wines from the Santa Cruz mountains region, breathtaking views, a spirited live auction featuring one-of-a-kind items, and most importantly, a chance to donate generously to support the Fogarty Institute’s mission to advance medical innovation and drastically improve patient care.

  • September 8, 2017 at 6:00pm
  • Thomas Fogarty Winery
    19501 Skyline Boulevard
    Woodside, CA 94062
  • 650-962-4560
READ MORE

Our history of Spearheading Innovation

COMPANY IN RESIDENCE

Logo

COMPANY IN RESIDENCE

Logo

EchoPixel, a startup that has developed a unique a medical visualization software platform, is undoubtedly one of the favorite stops when touring the Fogarty Institute.

Using 3D glasses and a special display, the company’s True 3D software system converts traditional CT images into interactive 3D renderings. With this system physicians can view and interact with anatomical structures as if they were real physical objects. The software offers an unprecedented way to examine patients' anatomy from every angle, making it easier to assess ailments and plan medical procedures.

EchoPixel’s software is being used in complex surgeries throughout the country, including a recent successful separation of conjoined twin sisters.

COMPANY IN RESIDENCE

Logo

COMPANY IN RESIDENCE

Logo

InterVene, a Fogarty Institute alumnus, has created a novel, minimally invasive device for the treatment of venous disease in the legs.

InterVene's technology represents the first non-implantable, catheter-based therapy to correct the underlying cause of chronic venous insufficiency (CVI). This condition is caused by improper function of the veins in the legs, which leads to blood pooling in the lower extremes, potentially causing skin changes and painful ulcerations. CVI afflicts approximately one quarter of adults and costs the U.S. healthcare system nearly $2 billion annually. To date, CVI treatment for patients with deep vein reflux is limited to compression stockings and wound care, or in rare cases, invasive surgery.

The company has moved into its new offices in South San Francisco, built its team to six members and added additional funding that helped develop a second-generation product, the BlueLeaf™ Endovenous Valve Formation System. The company is looking forward to gathering more clinical data in 2017 during an international extended feasibility study.

COMPANY IN RESIDENCE

Logo

COMPANY IN RESIDENCE

Logo

MedicalCue has developed a bedside tablet computer system that guides medical teams during newborn resuscitation. Much like a GPS offering real-time traffic avoidance, the startup's technology provides dynamic, real-time information needed during the complex steps of newborn resuscitation. The information provided to the delivery room staff is indexed to the national standard of care as developed by the American Academy of Pediatrics' Neonatal Resuscitation Program.

To make resuscitation easier, MedicalCue's system supplies both visual and audio information to clinicians. By automating routine tasks, such as record keeping and time keeping, this novel system also seeks to reduce the workload of nurses and doctors. Early testing of the system is demonstrating very promising results: In one study, the startup's device raised the accuracy of resuscitation delivery from approximately 55% to 95%.

MedicalCue is seeking to dramatically improve delivery room outcomes, considering that one in 10 babies globally need to be resuscitated at birth.

COMPANY IN RESIDENCE

Logo

COMPANY IN RESIDENCE

Logo

Zebra Medical Technology (ZTM) is creating the next generation of medical imaging that provides a non-invasive, real-time way to examine the skin and determine the potential presence of cancer. Over the past three decades, skin cancer has become the most prevalent type of cancer, outpacing all other types of cancer combined, including of the breast, lung and prostate.

Until today, cutting samples from the body for biopsy has been the only way to assess whether a new growth or lesion on the skin is cancerous. Of the 14.5 million biopsies conducted each year to determine the presence of skin cancer, nearly 76 percent reveal healthy tissue, creating an alarmingly high number of unneeded and costly procedures.

ZMT's patented handheld microscope, the EagleCyte, provides the immediate imaging features of an ultrasound, but with added cellular resolution and color contrast between cells and surrounding connective tissue that significantly improves pathology.

COMPANY IN RESIDENCE

Logo

COMPANY IN RESIDENCE

Logo

InPress Technologies, a Fogarty Institute graduate, has developed a simple device that is intended to quickly and effectively stop postpartum hemorrhage (PPH), the leading cause of maternal death globally, which takes the life of one woman every four minutes.

Nearly 80 percent of PPH cases are caused by uterine atony, or the failure of the uterus to contract to its correct postpartum size, which leaves intra-uterine blood vessels fully dilated. Women suffering from this condition are at risk of severe and dangerous blood loss that can lead to death.

Headed by Anne Morrissey as CEO and Jessie Becker as founder and COO, the startup has developed and patented the only device that treats uterine atony. Unlike other treatments available, its technology encourages the body’s natural response after childbirth by collapsing the uterus to its correct postpartum size to stop PPH.

InPress’ first-in-women clinical studies stopped postpartum hemorrhage within two minutes in all of its cases, without recurrence. The single-use device has the potential to dramatically reduce the cost of intervention during childbirth and substantially reduce the risk of loss of life, particularly in the developing world where the greatest incidence of maternal morbidity and mortality exist.

COMPANY IN RESIDENCE

Logo

COMPANY IN RESIDENCE

Logo

Materna is working to reduce the incidence of childbirth-related injuries and thereby the lifelong negative consequences women may experience due to such injuries. Approximately 11 percent of all women in the United States will undergo surgery to treat a pelvic floor disorder, and over one-third of all women currently suffer from symptoms. Materna’s first device prepares the pelvic soft tissues for delivery and has shown promise to prevent tears and pelvic muscle damage.

The company is currently preparing to launch its second device, Milli, which is aimed at treating pelvic pain, a condition that affects hundreds of thousands of women and often goes untreated. Materna originated from the Stanford Biodesign program.

COMPANY IN RESIDENCE

Logo

COMPANY IN RESIDENCE

Logo

nVision, a Fogarty Institute graduate, has long captured the interest of investors and healthcare professionals with its patented micro-catheter technology that allows unprecedented access to the fallopian tubes. The technology greatly expands diagnostic procedures that can be conducted in the gynecologist’s office, without painful incisions or general anesthesia, and allows detection of a host of clinical indications previously thought impossible.

Headed by founder, CEO and president Surbhi Sarna, the startup has developed two devices to aid clinicians in assessing tubal health: the first, Mako 7, allows physicians to access and collect cells from the fallopian tubes during a minimally invasive hysteroscopic procedure. The second device provides direct visualization of the fallopian tube lumen during hysteroscopy, which, when blocked, is one of the leading causes of infertility.

nVision has obtained FDA clearance for its first device, supported by a clinical study which demonstrated that 99 percent of the cell samples collected from the fallopian tube were adequate for further diagnostic evaluation.

First-in-women studies were successfully conducted for the second device and additional studies, followed by regulatory submissions, are planned.

COMPANY IN RESIDENCE

Logo

COMPANY IN RESIDENCE

Logo

Based in San Carlos, Calif., Prescient Surgical, a Fogarty Institute graduate, has developed a technology that holds the promise of reducing the incidence of surgical site infections (SSI).

Studies have shown that SSI adds $3 to 10 billion to the cost of healthcare each year in the U.S. alone. Between two and five percent of patients who undergo inpatient surgery will develop SSI, but those numbers increase significantly with higher-risk abdominal surgeries such as colorectal surgery, where infection rates commonly exceed 20 percent and result in higher treatment costs and longer hospital stays.

Prescient is expecting to receive 510(k) clearance shortly and is finishing development of an entire suite of products that target areas of acute need, including abdominal and laparoscopic surgeries, with pending expansion into vascular, orthopedic and endocrine surgeries.

The startup will initially focus on the U.S. market, followed by Europe and other continents as they continue to field interest from around the world.

Reinventing the Paradigm of Medtech Innovation

Logo

FEATURED AUCTION ITEM

Instant Santa Cruz Mountains Wine Party

Eight magnums of wine from Santa Cruz Mountains Wineries! Enjoy the finest varietals this region produces. The Santa Cruz Mountains have been recognized as a premium wine-producing region since the late 1800s when local winegrowers first began to win acclaim for their wines in national and international competitions. This is a perfect way to explore these wonderful wines!

DONATED BY Santa Cruz Mountains Winegrowers
Logo

FEATURED AUCTION ITEM

Instant Santa Cruz Mountains Wine Party

Eight magnums of wine from Santa Cruz Mountains Wineries! Enjoy the finest varietals this region produces. The Santa Cruz Mountains have been recognized as a premium wine-producing region since the late 1800s when local winegrowers first began to win acclaim for their wines in national and international competitions. This is a perfect way to explore these wonderful wines!

DONATED BY Santa Cruz Mountains Winegrowers
Logo

FEATURED AUCTION ITEM

Culinary Get Away to Italy

One week in Casa San Francesco in Cortona. Casa San Francesco is a completely restored home located in upper Cortona with wonderful views of rooftops and the valley below, as well as San Francesco church. 3 bedrooms – sleeps 6 - Book a stay at Casa San Francesco, and enjoy in-home cooking classes with host Ivan for some of the best Tuscan food you will ever eat!

DONATED BY Santa Cruz Mountains Winegrowers